Kendrick et al. [58] developed and tested a computerized method that uses advanced ML to identify and distinguish metastatic prostate cancer (mPCa) lesions in whole-body [68Ga]Ga-PSMA-11 PET/CT images. This evidence concerns the gene FOLH1 and metastatic prostate carcinoma.